Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Live and age well with REST in mind - investigating the signaling network of REST via gene editing and quantitative mass spectrometry in the context of Alzheimer's disease

EF 2014-15

Résumé
Alzheimer's disease (AD) can make ageing a frightening part of life. In 2014, a protein called the RE-1 silencing transcription factor (REST) made headlines as it was shown to be a protective factor against AD1. REST levels in the brains of healthily-aged human subjects were consistently higher than in subjects suffering from AD. Moreover, in response to toxic insults, REST levels rise and appear to offer protection1. Currently, urgently needed are insights on how REST is activated, how it renders protection, and what proteins it interacts with. My study aims to provide the first detailed molecular map of REST biology by elucidating its cellular activators, interactors, and targets. To monitor REST activation, I successfully created REST-knockout cells by replacing the REST gene with that of a fluorescent reporter protein (EGFP). I also generated cell clones that stably express an EGFP-REST fusion. The EGFP component allows its fusion proteins to be captured for biochemical analyses. I will expose cells to a variety of ageing-related insults to see which ones activate REST by measuring changes in the intensity of EGFP fluorescence. To see if the activated REST is indeed beneficial, I will examine changes in the levels of known survival-promoting proteins (e.g. neurotrophic factors2) versus that of harmful proteins (e.g. caspase-33). To determine the signaling activators, interactors, and targets of REST, I will use modern mass spectrometry, which can quantify 50% of all proteins in a given cell type in just 4 hours4. REST has certainly spurred hope as a new intervention for treating AD. However, before developing any therapeutic plans, a thorough characterization of REST biology is crucial to assess specificity, efficacy, and safety.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
331442
Name
Wang Xinzhu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Live and age well with REST in mind - investigating the signaling network of REST via gene editing and quantitative mass spectrometry in the context of Alzheimer's disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Crispr Cas9; Gene Editing; Global Proteome; Interactome; Molecular Network; Neurodegeneration; Re-1 Silencing Transcription Factor (Rest)
Abstract
Alzheimer's disease (AD) can make ageing a frightening part of life. In 2014, a protein called the RE-1 silencing transcription factor (REST) made headlines as it was shown to be a protective factor against AD1. REST levels in the brains of healthily-aged human subjects were consistently higher than in subjects suffering from AD. Moreover, in response to toxic insults, REST levels rise and appear to offer protection1. Currently, urgently needed are insights on how REST is activated, how it renders protection, and what proteins it interacts with. My study aims to provide the first detailed molecular map of REST biology by elucidating its cellular activators, interactors, and targets. To monitor REST activation, I successfully created REST-knockout cells by replacing the REST gene with that of a fluorescent reporter protein (EGFP). I also generated cell clones that stably express an EGFP-REST fusion. The EGFP component allows its fusion proteins to be captured for biochemical analyses. I will expose cells to a variety of ageing-related insults to see which ones activate REST by measuring changes in the intensity of EGFP fluorescence. To see if the activated REST is indeed beneficial, I will examine changes in the levels of known survival-promoting proteins (e.g. neurotrophic factors2) versus that of harmful proteins (e.g. caspase-33). To determine the signaling activators, interactors, and targets of REST, I will use modern mass spectrometry, which can quantify 50% of all proteins in a given cell type in just 4 hours4. REST has certainly spurred hope as a new intervention for treating AD. However, before developing any therapeutic plans, a thorough characterization of REST biology is crucial to assess specificity, efficacy, and safety.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wang, Xinzhu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~